Less-invasive and highly effective method for preventing methicillin-resistant Staphylococcus aureus graft infection

Hisashi Sakaguchi1, Akira Marui, Keiichi Hirose

  • 1Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Abstract

Insights

A novel vancomycin-eluting sheet effectively prevented methicillin-resistant Staphylococcus aureus graft infections in a murine model. This local sustained-release approach significantly reduced bacterial counts and improved survival rates.

Area of Science:

  • Biomaterials Science
  • Infectious Disease Research
  • Vascular Surgery

Background:

  • Prosthetic vascular graft infections, particularly by methicillin-resistant Staphylococcus aureus (MRSA), pose serious complications in vascular surgery.
  • Systemic vancomycin administration shows limited efficacy against established MRSA graft infections.
  • Developing localized treatment strategies is crucial for preventing and managing these infections.

Purpose of the Study:

  • To investigate the efficacy of a locally sustained-release vancomycin-eluting poly-L-lactide-co-caprolactone (PLCA) sheet in preventing MRSA vascular graft infections.
  • To evaluate the impact of this localized treatment on bacterial load, sepsis development, and survival rates.

Main Methods:

  • Development of a PLCA sheet for sustained vancomycin release over two weeks.
  • Suturing of expanded polytetrafluoroethylene vascular graft patches onto murine aortas.
  • Inoculation of MRSA onto grafts, followed by treatment with no intervention, vancomycin solution, or vancomycin-PLCA sheet.
  • Post-treatment assessment of graft bacterial counts, blood cultures, and survival rates at 7 and 28 days.

Main Results:

  • The vancomycin-PLCA group exhibited significantly lower MRSA counts in grafts compared to control and vancomycin solution groups.
  • All blood cultures in the vancomycin-PLCA group were negative for infection, while others were positive.
  • Survival rates at 28 days were substantially higher in the vancomycin-PLCA group (83.3%) versus the control group (16.7%).

Conclusions:

  • Local sustained release of vancomycin via a PLCA sheet effectively reduces MRSA in infected vascular grafts.
  • This localized treatment prevents sepsis and significantly improves survival rates in a murine model.
  • The vancomycin-PLCA sheet represents a promising, less-invasive adjunctive therapy for preventing prosthetic MRSA graft infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia01:30

Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia

Depending on the target organ, local anesthetics (LAs) can be administered via various routes. In surface anesthesia, LAs are applied directly to the surface of the skin or mucous membranes. It is widely used for topical skin numbing before venipuncture or minor surgical procedures. Commonly used surface local anesthetics are lidocaine or benzocaine sprays or creams. Surface anesthesia occurs within 5 minutes and lasts for about 60 minutes. One of the main disadvantages of topical anesthesia is...
Local Anesthetics: Pharmacokinetics01:13

Local Anesthetics: Pharmacokinetics

The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...